Alemtuzumab vs. Interferon Beta-1a in Early Multiple SclerosisNEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple SclerosisNEJM 354:911-923,965, Rudick,R.A.,et al, 2006